A carregar...
Pharmacokinetics of Peramivir in an Adolescent Patient Receiving Continuous Venovenous Hemodiafiltration
Critically ill patients requiring renal replacement therapy commonly experience pharmacokinetic alterations. This case report describes the pharmacokinetics of peramivir (Rapivab, BioCryst Pharmaceuticals, Inc, Durham, NC), the first US Food and Drug Administration–approved intravenous neuraminidase...
Na minha lista:
| Publicado no: | J Pediatr Pharmacol Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pediatric Pharmacy Advocacy Group
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341533/ https://ncbi.nlm.nih.gov/pubmed/28337082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-22.1.60 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|